Chase AIPricingFAQs
Display currency
Loading news…

Enorama Pharma

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Malmö, Skane Lan, Sweden Founded 2006 1-10 employees For Profit

Enorama Pharma is a manufacturer of nicotine chewing gums and pouches used for quitting smoking.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
0
Ticker
ERMA
STO - Stockholm Stock Exchange
Patents
4
16 trademarks

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Public
Ticker
ERMA
Exchange
STO - Stockholm Stock Exchange
IPO date
Jun 10, 2016

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
5
Patents granted
4
Trademarks
16
Top patent class
Medical Or Veterinary Science; Hygiene
IT spend
$90K

Company Info

Founded
2006
Employees
1-10
Operating status
Active
Company type
For Profit
Org types
company
Founders
1
News articles
12
HQ
Malmö, Skane Lan, Sweden
Region
European Union (EU), Nordic Countries, Scandinavia
Exit date
Jun 10, 2016

Signals & Scores

Heat score
High
Growth score
High
Trend (7d)
-0.2
Trend (30d)
1.5
Trend (90d)
-0.1
Last leadership hire
Jun 16, 2026

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Enorama Pharma

Loading news…

FAQs about Enorama Pharma

People who checked this page also checked these

Browse the full Acquirezy directory.
Enorama Pharma - Company Profile, Full Acquisitions List, Funding and Investments